— Know what they know.
Not Investment Advice

BIOQ OTC

Bioqual, Inc.
1W: +0.0% 1M: +0.0% 3M: +1.5% YTD: -14.3% 1Y: -17.5% 3Y: -44.1% 5Y: -59.2%
$33.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Diagnostics & Research · Tech Score Neutral · Power 55 · $29.5M mcap · 890748 float · 0.064% daily turnover · Short 74% of daily vol

Balance Sheet Trends

Total Assets
$57M +0.9% ▲
5Y CAGR: +2.9%
Total Liabilities
$21M +10.7% ▲
5Y CAGR: -0.4%
Shareholders Equity
$36M -4.0% ▼
5Y CAGR: +5.1%
Cash & Investments
$18M +14.5% ▲
5Y CAGR: +11.7%
Total Debt
$17M +361.1% ▲
5Y CAGR: +0.5%
Net Debt
-$1M +89.1% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$8M$2M$7M$16M$18M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$8M$2M$7M$16M$18M
Net Receivables$20M$27M$21M$14M$13M
Inventory$0$0$0$0$0
Other Current Assets$0$0$0$0$288K
Total Current Assets$29M$32M$30M$31M$31M
Property, Plant & Equip.$23M$31M$30M$25M$24M
Goodwill & Intangibles$1M$1M$1M$1M$1M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$112K$0$0$0$0
Total Non-Current Assets$24M$32M$31M$26M$26M
Total Assets$53M$63M$61M$57M$57M
— Liabilities —
Accounts Payable$2M$3M$2M$1M$2M
Short-Term Debt$3M$3M$3M$4M$4M
Deferred Revenue$876K$1M$957K$446K$737K
Other Current Liabilities$0$2M$2M$0$0
Total Current Liabilities$9M$10M$8M$8M$8M
Long-Term Debt$0$16M$15M$0$0
Other Non-Current Liab.-$11M-$15M-$15M$0$0
Total Non-Current Liabilities$11M$16M$15M$11M$13M
Total Liabilities$20M$26M$24M$19M$21M
— Equity —
Common Stock$16K$16K$16K$16K$16K
Retained Earnings$27M$31M$31M$31M$30M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$34M$38M$38M$38M$36M
Total Liabilities & Equity$53M$63M$61M$57M$57M
— Key Metrics —
Total Debt$15M$19M$19M$4M$17M
Net Debt$7M$17M$8M-$12M-$1M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms